The latest price target for Exelixis (NASDAQ:EXEL) was reported by UBS on September 19, 2024. The analyst firm set a price target for $30.00 expecting EXEL to rise to within 12 months (a possible 11.82% upside). 23 analyst firms have reported ratings in the last year.

The latest analyst rating for Exelixis (NASDAQ:EXEL) was provided by UBS, and Exelixis initiated their neutral rating.

There is no last upgrade for Exelixis

The last downgrade for Exelixis Inc happened on April 11, 2024 when Barclays changed their price target from $25 to $25 for Exelixis Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exelixis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exelixis was filed on September 19, 2024 so you should expect the next rating to be made available sometime around September 19, 2025.

While ratings are subjective and will change, the latest Exelixis (EXEL) rating was a initiated with a price target of $0.00 to $30.00. The current price Exelixis (EXEL) is trading at is $26.83, which is within the analyst’s predicted range.